Since 2016, StemLife has become a subsidiary of Cordlife Group Limited, a Singapore Exchange mainboard-listed company in Singapore.
Cordlife Group Limited has a large network of cord blood banks in Asia, that has cord blood and cord lining processing and storage facilities.
As a Group, Cordlife has made 71 cord blood releases, all of which have been used successfully in transplants or cellular therapy. This is the ultimate validation of our cord blood processing and storage capability.
76
Total releases by StemLife
19
Cerebral Palsy
20
Autism Spectrum Disorder (ASD)
16
Thalassaemia Major
8
Leukaemia
3
Neuroblastoma
3
Hypoxic-Ischemic Encephalopathy
2
Brain Injury
1
Developmental Dyspraxia
1
Fanconi Anaemia
1
Sickle Cell Anaemia
1
Global Development Delay
1
Aplastic Anaemia
| Years released | 2009 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 28.1 |
| Healthcare Institution | Mount Elizabeth Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 80% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2009 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 38.8 |
| Healthcare Institution | Private Hospital, Bangkok |
| Banked by | Stemlife Malaysia |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Thailand |
| Years released | 2009 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 30.6 |
| Healthcare Institution | Private Hospital, Bangkok |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Thailand |
| Years released | 2010 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 18.7 |
| Healthcare Institution | Mount Elizabeth Hospital |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2010 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 42.0 |
| Healthcare Institution | Duke University Hospital |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Hong Kong |
| Treatment Country | United States |
| Years released | 2010 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 14.5 |
| Healthcare Institution | Private Hospital, Bangkok |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Thailand |
| Years released | 2010 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 7.4 |
| Healthcare Institution | Private Hospital, Bangkok |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Thailand |
| Years released | 2011 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 12.5 |
| Healthcare Institution | Duke University Hospital |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Hong Kong |
| Treatment Country | United States |
| Years released | 2012 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 20.6 |
| Healthcare Institution | Duke University Hospital |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | United States |
| Years released | 2014 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 7.0 |
| Healthcare Institution | Madonna and Child Hospital |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Philippines |
| Treatment Country | Philippines |
| Years released | 2014 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 33.8 |
| Healthcare Institution | CHA Bundang Medical Center |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | South Korea |
| Years released | 2014 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 33.8 |
| Healthcare Institution | CHA Bundang Medical Center |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 80% |
| Storage Country | Singapore |
| Treatment Country | South Korea |
| Years released | 2014 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 57.3 |
| Healthcare Institution | Mount Elizabeth Hospital |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 80% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2015 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 21.1 |
| Healthcare Institution | Mount Elizabeth Hospital |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 80% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2015 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 26.0 |
| Healthcare Institution | Mount Elizabeth Hospital |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2015 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 19.2 |
| Healthcare Institution | Duke University Hospita |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | India |
| Treatment Country | United States |
| Years released | 2015 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 67.3 |
| Healthcare Institution | Mount Elizabeth Hospital |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 20% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2017 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 47.9 |
| Healthcare Institution | Mount Elizabeth Hospital |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 20% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2018 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 26.3 |
| Healthcare Institution | Mount Elizabeth Hospital |
| Banked by | 0000 |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2006 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | N/A |
| Healthcare Institution | University Malaya Medical Centre |
| Banked by | Stemlife Malaysia |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Malaysia |
| Years released | 2008 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 19.4 |
| Healthcare Institution | University Malaya Medical Centre |
| Banked by | Stemlife Malaysia |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Malaysia |
| Years released | 2010 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 14.6 |
| Healthcare Institution | Institut Pediatrik, GHKL |
| Banked by | Stemlife Malaysia |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Malaysia |
| Years released | 2010 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | N/A |
| Healthcare Institution | Institut Pediatrik, GHKL |
| Banked by | Stemlife Malaysia |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Malaysia |
| Years released | 2011 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major (E beta Thalassemia) |
| Storage time (months) | 24.4 |
| Healthcare Institution | Netaji Subhash Chandra Bose Cancer Research Institute |
| Banked by | Cordlife India |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | India |
| Treatment Country | India |
| Years released | 2013 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 37.5 |
| Healthcare Institution | University Malaya Medical Centre |
| Banked by | Stemlife Malaysia |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Malaysia |
| Years released | 2014 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 44.9 |
| Healthcare Institution | Institut Pediatrik, GHKL |
| Banked by | Stemlife Malaysia |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Malaysia |
| Years released | 2015 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 15.8 |
| Healthcare Institution | Apollo Speciality Hospital |
| Banked by | Cordlife India |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | India |
| Treatment Country | India |
| Years released | 2015 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 25.4 |
| Healthcare Institution | Queen Mary Hospital |
| Banked by | Cordlife Hong Kong |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Hong Kong |
| Treatment Country | China |
| Years released | 2015 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 13.8 |
| Healthcare Institution | University Malaya Medical Centre |
| Banked by | Stemlife Malaysia |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Malaysia |
| Years released | 2017 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 63.0 |
| Healthcare Institution | Tata Medical Center |
| Banked by | Cordlife India |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | India |
| Treatment Country | India |
| Years released | 2019 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 22.1 |
| Healthcare Institution | Dr. Balabhai Nanavati Hospital |
| Banked by | Cordlife India |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | India |
| Treatment Country | India |
| Years released | 2021 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 19.5 |
| Healthcare Institution | Apollo Speciality Hospital |
| Banked by | Cordlife India |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | India |
| Treatment Country | India |
| Years released | 2021 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 48.5 |
| Healthcare Institution | Hong Kong Children's Hospital |
| Banked by | Healthbaby Hong Kong |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Hong Kong |
| Treatment Country | China |
| Years released | 2023 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 17 |
| Healthcare Institution | Max Super Speciality Hospital, Delhi |
| Banked by | Cordlife India |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | India |
| Treatment Country | India |
| Years released | 2023 |
| Unit usage | Sibling |
| Indications | Thalassaemia Major |
| Storage time (months) | 43 |
| Healthcare Institution | Narayana Health City, Bangalore |
| Banked by | Cordlife India |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | India |
| Treatment Country | India |
| Years released | 2010 |
| Unit usage | Self |
| Indications | Neuroblastoma |
| Storage time (months) | 35.0 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2011 |
| Unit usage | Self |
| Indications | Neuroblastoma |
| Storage time (months) | 29.3 |
| Healthcare Institution | Queen Mary Hospital |
| Banked by | Cordlife Hong Kong |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Hong Kong |
| Treatment Country | China |
| Years released | 2013 |
| Unit usage | Self |
| Indications | Neuroblastoma |
| Storage time (months) | 70.9 |
| Healthcare Institution | Queen Mary Hospital |
| Banked by | Healthbaby Hong Kong |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Hong Kong |
| Treatment Country | China |
| Years released | 2009 |
| Unit usage | Self |
| Indications | Brain Injury |
| Storage time (months) | 11.3 |
| Healthcare Institution | Private Hospital, Bangkok |
| Banked by | Stemlife Malaysia |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Thailand |
| Years released | 2011 |
| Unit usage | Self |
| Indications | Brain Injury |
| Storage time (months) | 35.6 |
| Healthcare Institution | Private Hospital, Bangkok |
| Banked by | Stemlife Malaysia |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Thailand |
| Years released | 2014 |
| Unit usage | Sibling |
| Indications | Fanconi Anaemia and marrow failure |
| Storage time (months) | 49.5 |
| Healthcare Institution | Queen Mary Hospital |
| Banked by | Healthbaby Hong Kong |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Hong Kong |
| Treatment Country | China |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Global Development Delay |
| Storage time (months) | 50.1 |
| Healthcare Institution | Vinmec Research Institute of Stem Cell and Gene Technology |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Vietnam |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 71.5 |
| Healthcare Institution | Gleneagles Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Malaysia |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 92.0 |
| Healthcare Institution | Gleneagles Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Malaysia |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 92.8 |
| Healthcare Institution | Gleneagles Hospital |
| Banked by | Stemlife Malaysia |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Malaysia |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 78.4 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 67.7 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 133.3 |
| Healthcare Institution | Gleneagles Hospital |
| Banked by | Stemlife Malaysia |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Malaysia |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 110.1 |
| Healthcare Institution | Duke University Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | United States |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 47.7 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 112.5 |
| Healthcare Institution | Gleneagles Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Malaysia |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 54.4 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 59.8 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 80% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2020 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 59.7 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2020 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 52.3 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2020 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 60.0 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2021 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 49.4 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Philippines |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Philippines |
| Treatment Country | Singapore |
| Years released | 2021 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 45.7 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2021 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 65.1 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2021 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 63.2 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2023 |
| Unit usage | Sibling |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 6.6 |
| Healthcare Institution | Celltech Stem Cell Centre |
| Banked by | Cordlife Indonesia |
| Transplant type | Allogenic |
| % unit used | 20% |
| Storage Country | Indonesia |
| Treatment Country | Indonesia |
| Years released | 2023 |
| Unit usage | Self |
| Indications | Autism Spectrum Disorder |
| Storage time (months) | 52 |
| Healthcare Institution | Private Hospital, Philippines |
| Banked by | Cordlife Philippines |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Philippines |
| Treatment Country | Philippines |
| Years released | 2002 |
| Unit usage | Sibling |
| Indications | Acute Lymphoblastic Leukaemia |
| Storage time (months) | 5.5 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2002 |
| Unit usage | Sibling |
| Indications | Acute Lymphoblastic Leukaemia |
| Storage time (months) | 1.1 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2006 |
| Unit usage | Sibling |
| Indications | Acute Myeloid Leukaemia |
| Storage time (months) | 32.1 |
| Healthcare Institution | University Malaya Medical Centre |
| Banked by | Stemlife Malaysia |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Malaysia |
| Years released | 2007 |
| Unit usage | Sibling |
| Indications | Acute Lymphoblastic Leukaemia |
| Storage time (months) | N/A |
| Healthcare Institution | University Malaya Medical Centre |
| Banked by | Stemlife Malaysia |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Malaysia |
| Years released | 2012 |
| Unit usage | Sibling |
| Indications | Acute Myeloblastic Leukaemia |
| Storage time (months) | 13.2 |
| Healthcare Institution | Peking University First Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | China |
| Years released | 2013 |
| Unit usage | Sibling |
| Indications | Juvenile Myelomonocytic Leukaemia |
| Storage time (months) | 4.2 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2018 |
| Unit usage | Sibling |
| Indications | Chronic Myeloid Leukaemia |
| Storage time (months) | 32.9 |
| Healthcare Institution | University Malaya Medical Centre |
| Banked by | Stemlife Malaysia |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | Malaysia |
| Years released | 2018 |
| Unit usage | Sibling |
| Indications | Acute Lymphoblastic Leukaemia |
| Storage time (months) | 119.3 |
| Healthcare Institution | KK Women's & Children's Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2014 |
| Unit usage | Self |
| Indications | Hypoxic Ischemic Encephalopathy |
| Storage time (months) | 6.0 |
| Healthcare Institution | Mount Elizabeth Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Hypoxic Ischemic Encephalopathyand Cystic Encephalomalacia |
| Storage time (months) | 2.5 |
| Healthcare Institution | Duke University Hospital |
| Banked by | Cordlife India |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | India |
| Treatment Country | United States |
| Years released | 2022 |
| Unit usage | Self |
| Indications | Hypoxic Ischemic Encephalopathy |
| Storage time (months) | 8.4 |
| Healthcare Institution | Hong Kong Children's Hospital |
| Banked by | Cordlife Hong Kong |
| Transplant type | AutologousSelf |
| % unit used | 100% |
| Storage Country | Hong Kong |
| Treatment Country | China |
| Years released | 2019 |
| Unit usage | Self |
| Indications | Developmental Dyspraxia |
| Storage time (months) | 79.6 |
| Healthcare Institution | Duke University Hospital |
| Banked by | Stemlife Malaysia |
| Transplant type | Autologous |
| % unit used | 100% |
| Storage Country | Malaysia |
| Treatment Country | United States |
| Years released | 2020 |
| Unit usage | Sibling |
| Indications | Sickle cell Anaemia |
| Storage time (months) | 15.2 |
| Healthcare Institution | Indraprastha Apollo Hospital |
| Banked by | Cordlife India |
| Transplant type | Allogeneic |
| % unit used | 100% |
| Storage Country | India |
| Treatment Country | India |
| Years released | 2022 |
| Unit usage | Self |
| Indications | Aplastic Anaemia |
| Storage time (months) | 81.5 |
| Healthcare Institution | Mount Elizabeth Hospital |
| Banked by | Cordlife Singapore |
| Transplant type | Autologus |
| % unit used | 100% |
| Storage Country | Singapore |
| Treatment Country | Singapore |
FOOTNOTES:
- Storage time: The number of months the sample is stored prior to transplants.
^ Cord blood units sent to South Korea were used for two separate infusions for two children (twins). - Some releases may be for the same client but released in different periods.
- This list shows the cord blood released by Cordlife Group Limited and its group of subsidiaries to support the treatment of various diseases.This should not be used as a reference for the list of treatable diseases by cord blood stem cells. In addition, banking your baby’s cord blood does not guarantee that the stem cells will provide a cure or be applicable for every situation. The use is ultimately determined by the treating physician.Following respective countries regulatory requirements at the time of cord blood release.
Cordlife Group Cord Lining Transplants
The table below features the cord lining/tissue releases performed by Cordlife Group Limited and its group of subsidiaries.
| Years released | 2015 |
| Unit usage | Self |
| Indications | Cerebral Palsy |
| Storage time (months) | 7.1 |
| Healthcare Institution | RS Mayapada |
| Banked by | Cordlife Indonesia |
| Transplant type | Autologous |
| Vials used | 1 |
| Storage Country | Indonesia |
| Treatment Country | Indonesia |
| Years released | 2016 |
| Unit usage | Sibling |
| Indications | Cerebral Palsy |
| Storage time (months) | 12.3 |
| Healthcare Institution | RS Harapan Kita / RS Mayapada |
| Banked by | Cordlife Indonesia |
| Transplant type | Allogeneic |
| Vials used | 1 |
| Storage Country | Indonesia |
| Treatment Country | Indonesia |
| Years released | 2018 |
| Unit usage | Sibling |
| Indications | Cerebral Palsy |
| Storage time (months) | 7.7 |
| Healthcare Institution | RS Cipto Mangunkusumo |
| Banked by | Cordlife Indonesia |
| Transplant type | Allogeneic |
| Vials used | 1 |
| Storage Country | Indonesia |
| Treatment Country | Indonesia |
| Years released | 2017 |
| Unit usage | Sibling |
| Indications | Spina Bifida |
| Storage time (months) | 10.8 |
| Healthcare Institution | RS PON |
| Banked by | Cordlife Indonesia |
| Transplant type | Allogeneic |
| Vials used | 1 |
| Storage Country | Indonesia |
| Treatment Country | Indonesia |
| Years released | 2019 |
| Unit usage | Grandfather |
| Indications | Kidney Disease |
| Storage time (months) | 26.8 |
| Healthcare Institution | Vinski Regenerative Centre |
| Banked by | Cordlife Indonesia |
| Transplant type | Allogeneic |
| Vials used | 1 |
| Storage Country | Indonesia |
| Treatment Country | Indonesia |
| Years released | 2017 |
| Unit usage | Grandfather |
| Indications | Dementia |
| Storage time (months) | 3.6 |
| Healthcare Institution | RS Medistra |
| Banked by | Cordlife Indonesia |
| Transplant type | Allogeneic |
| Vials used | 2 |
| Storage Country | Indonesia |
| Treatment Country | Indonesia |
| Years released | 2018 |
| Unit usage | Grandfather |
| Indications | Diabetes |
| Storage time (months) | 16.7 |
| Healthcare Institution | RS Medistra |
| Banked by | Cordlife Indonesia |
| Transplant type | Allogeneic |
| Vials used | 1 |
| Storage Country | Indonesia |
| Treatment Country | Indonesia |
| Years released | 2021 |
| Unit usage | Grandfather |
| Indications | Stroke |
| Storage time (months) | 5.5 |
| Healthcare Institution | Vinski Regenerative Centre |
| Banked by | Cordlife Indonesia |
| Transplant type | Allogeneic |
| Vials used | 1 |
| Storage Country | Indonesia |
| Treatment Country | Indonesia |
FOOTNOTES:
- This list shows the cord lining/tissue released by Cordlife Group Limited and its group of subsidiaries to support the treatment of various diseases. This should not be used as a reference for the list of treatable diseases by cord lining/tissue stem cells. In addition, banking your baby’s cord lining/tissue does not guarantee that the stem cells will provide a cure or be applicable for every situation. The use is ultimately determined by the treating physician.Following respective countries regulatory requirements at the time of cord blood release. Some releases may be for the same client but released in different period.
Have you considered saving your cord blood and cord lining so that you can take advantage of the medical potentials that the stem cells within them contain?
Get in touch with us NOW.
